Genomic Features Do Not Account for Differences in Multiple Myeloma Risk by Ancestry.

Maclachlan, Kylee H; Hassoun, Hani; Landgren, Ola; Weinhold, Niels; Poos, Alexandra; Tan, Carlyn; Zhang, Yanming; Tang, Hongwei; Diamond, Benjamin; Usmani, Saad Z; Brown, Elizabeth E; Baughn, Linda B; Cimera, Robert; Steinsnyder, Zoe; Raab, Marc-Steffen; Robine, Nicolas; Dogan, Ahmet; Maura, Francesco; Mailankody, Sham; Winterkorn, Lara; Ziccheddu, Bachisio; Davies, Faith E; Chu, Timothy; Papadimitriou, Marios; Shekarkhand, Tala; Blaney, Patrick; Hultcrantz, Malin; Vaksman, Zalman; Shah, Urvi A; Korde, Neha; Gagler, Dylan; Boyle, Eileen; Morgan, Gareth J; Lesokhin, Alexander M; Yan, Huihuang

doi:10.1158/2643-3230.BCD-25-0259

Journal Article

DKFZ-2026-02198

Genomic Features Do Not Account for Differences in Multiple Myeloma Risk by Ancestry.

Maclachlan, K. H. ; Papadimitriou, M. ; Blaney, P. ; Baughn, L. B. ; Shekarkhand, T. ; Poos, A.DKFZ* ; Ziccheddu, B. ; Tang, H. ; Yan, H. ; Diamond, B. ; Zhang, Y. ; Cimera, R. ; Dogan, A. ; Gagler, D. ; Boyle, E. ; Hultcrantz, M. ; Mailankody, S. ; Hassoun, H. ; Shah, U. A. ; Tan, C. ; Brown, E. E. ; Winterkorn, L. ; Chu, T. ; Steinsnyder, Z. ; Vaksman, Z. ; Davies, F. E. ; Korde, N. ; Landgren, O. ; Raab, M.-S.DKFZ* ; Lesokhin, A. M. ; Robine, N. ; Weinhold, N.DKFZ* ; Usmani, S. Z. ; Maura, F. ; Morgan, G. J.

2026
American Association for Cancer Research Philadelphia, PA

Blood cancer discovery 7(5), 742 - 758 (2026) [10.1158/2643-3230.BCD-25-0259]

Abstract: Studies have reported conflicting findings regarding the contribution of germline variants or somatic genomic drivers to racial disparities in multiple myeloma. To comprehensively investigate somatic drivers in relation to inherited genetics in multiple myeloma, we combined newly sequenced whole-genome sequencing data with publicly available datasets (total n = 1,286). Overall, we did not identify germline or somatic genomic differences that explain the different risk of developing multiple myeloma between patients with genetic similarity to African (AFR) or European (EUR) reference populations. A difference in the detectability and timing of APOBEC-associated and germinal center mutational activity was observed. Integrating epidemiologic data and mutational signature-based temporal estimates, we challenge the assumption that individuals in the AFR group develop multiple myeloma at a younger age. Finally, we demonstrate that, with equal access to efficacious therapies, patients in the AFR and EUR groups have equivalent clinical outcomes.Multiple myeloma is reported to occur at higher rates in individuals who self-identify as non-Hispanic Black. In this large dataset, genomic drivers occur at the same rate among ancestry groups, except for APOBEC mutagenesis. With equivalent therapy, clinical outcomes did not differ for patients grouped by genetic ancestry similarity.

Keyword(s): Humans (MeSH) ; Multiple Myeloma: genetics (MeSH) ; Multiple Myeloma: epidemiology (MeSH) ; Genomics: methods (MeSH) ; Genetic Predisposition to Disease (MeSH) ; White People: genetics (MeSH) ; Female (MeSH) ; Male (MeSH) ; European People (MeSH)